Iovision

Iohexol, the active ingredient in Iovision, is a iodinated non‑ionic contrast media presented as a solution for intraarterial, intrathecal, and intravenous use. It enhances radiographic imaging of vascular and other structures during diagnostic procedures. GNH USA supplies Iovision as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iovision is an iodinated non‑ionic contrast agent used to improve visualization in several imaging procedures.

- Angiography: enhances the delineation of blood vessels and vascular pathology during vascular imaging. - Myelography: provides contrast for detailed imaging of the spinal canal and nerve roots. - Computed Tomography (CT) imaging: improves differentiation of anatomical structures and lesions, aiding diagnostic accuracy.

Adverse reactions to Iovision can range from mild to severe and should be monitored during and after administration.

Common Side Effects: - Warmth or flushing sensation at injection site. - Metallic taste in the mouth. - Nausea or vomiting. - Mild headache. - Transient hypotension. - Mild itching or rash.

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis. - Acute renal impairment or failure. - Persistent hypotension or cardiovascular collapse. - Seizures or convulsions. - Cardiac arrhythmias. - Pulmonary edema or respiratory distress.

Prior to using Iovision, clinicians should consider several safety measures.

- Renal function assessment: evaluate serum creatinine and eGFR to reduce risk of nephrotoxicity. - Iodine allergy history: confirm no prior severe reactions to iodinated contrast. - Thyroid disease evaluation: avoid in patients with uncontrolled hyperthyroidism. - Dose minimization: use the lowest effective volume for the specific imaging study. - Patient monitoring: observe vital signs and symptoms during and after injection. - Store at room temperature: keep in original container, protect from light and moisture.

Iovision may interact with other medications or agents, influencing safety and efficacy.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents. - High‑dose nephrotoxic drugs such as aminoglycoside antibiotics. - Loop diuretics administered shortly before contrast injection. - Metformin in patients with impaired renal function. - Radiopharmaceuticals that rely on iodine uptake.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may affect renal perfusion. - ACE inhibitors or ARBs, which can potentiate renal effects. - Beta‑blockers influencing cardiovascular response. - Thyroid hormone replacement therapy. - Calcium channel blockers that may alter hemodynamics.